The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); Roche (Inst)
 
Jacinta Abraham
Consulting or Advisory Role - Genomic Health; Pfizer
Travel, Accommodations, Expenses - Genomic Health; Novartis
 
Stephen Chan
No Relationships to Disclose
 
Duncan Wheatley
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Murray Brunt
Honoraria - Eisai; Genomic Health; Roche
Consulting or Advisory Role - Celldex; Eisai; Genomic Health; Roche
Travel, Accommodations, Expenses - Celldex (I); Eisai; Genomic Health; Roche
 
Gia Nemsadze
No Relationships to Disclose
 
Richard Baird
Consulting or Advisory Role - Daiichi Sankyo (Inst); Molecular Partners (Inst); Shionogi (Inst)
Research Funding - AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Molecular Partners (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Molecular Partners; Shionogi
 
Yeon Hee Park
No Relationships to Disclose
 
Peter Hall
Research Funding - Amgen (Inst); AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
 
Timothy Perren
No Relationships to Disclose
 
Robert C. Stein
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - Novartis Pharmaceuticals UK Ltd.
 
Mangel László
No Relationships to Disclose
 
Jean-Marc Ferrero
No Relationships to Disclose
 
Melissa Phillips
No Relationships to Disclose
 
John Conibear
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; MSD
 
Shah-Jalal Sarker
No Relationships to Disclose
 
Aaron Prendergast
No Relationships to Disclose
 
Hayley Cartwright
No Relationships to Disclose
 
Kelly Mousa
No Relationships to Disclose
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche; Synthon; Tesaro
Research Funding - AstraZeneca (Inst); Bio-Rad (Inst); Clovis Oncology (Inst); Inivata (Inst); Pfizer (Inst); Roche (Inst)